Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.
Bristol-Myers Squibb Co (BMY) Profile
Biopharmaceutical products are developed, manufactured and
marketed by Bristol-Myers Squibb. The company sells products in hematology, oncology,
cardiology, and immunology. The company's products include Revlimid, an oral immunomodulatory
drug for the treatment of multiple myeloma, Opdivo, an anti-cancer drug, Eliquis, an oral
inhibitor for the prevention of stroke/systemic embolism in patients with NVAF, and Orencia, for
the management of DVT/PE in adults. It also offers Sprycel for the treatment of Philadelphia
chromosome-positive chronic myeloid leukemia, Yervoy for unresectable or metastatic melanoma,
Abraxane, a protein-bound chemotherapeutic product, mpliciti for multiple myeloma, and Reblozyl
for anemia in adult beta thalassemia sufferers. It also offers Onureg for AML, Zeposia for
relapsing MS, Vidaza for MDS subtypes, Baraclude, an oral antiviral for chronic hepatitis B, and
Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for relapsed or
refractory large B-cell lymphoma. Companies such as this one sell to hospitals and government
agencies as well as wholesalers. • Pfizer; Otsuka; Ono; Nektar; AVEO; Huyabio; Darwin Health;
Inspirna; and Bolt Biotherapeutics; Originally known as Bristol-Myers Squibb. Bristol-Myers
Squibb is headquartered in New York, New York.
Full Time Employees: 30,250. Latest stock price 64.72-0.17 (-0.26%)
At close: 04:00PM EST.19th January 2022, Total assets for the quarter ending September 30, 2021
were $110.893B, Subsidiaries: Celgene, MyoKardia, Inc., Juno Therapeutics, Union de
Pharmacologie Scientifique Appliquée, Bristol Myers Squibb Pharmaceuticals and more.
Bristol-Myers Squibb Co (BMY.xnys) Analysis
Thu, January 20, 2022, 5:50 AM
Bristol Myers Squibb (BMY) closed the most recent trading day at $64.72, moving -0.26% from the
previous trading session. This change was narrower than the S&P 500's daily loss of 0.97%.
Meanwhile, the Dow lost 0.96%, and the Nasdaq, a tech-heavy index, added 0.23%.
Increase your ability
to profit in
all
market conditions
Leverage options up to 20:1
Real-time, transparent
share prices
Control, Functionality and deep liquidity
Full Market depth & see your orders in the queue
MT4, MT5, Webtrader & Iress with
superior client portal
Award winning support &
personal account managers
Low margins and competitive commission
+10,000 products on global stocks
across 4 continents
On long positions
No ownership of physical
shares necessary
Bằng việc cung cấp email của mình, bạn đồng ý với chính sách về quyền riêng tư của FP Markets và nhận các tài liệu marketing trong tương lai từ FP Markets. Bạn có thể hủy đăng ký bất cứ lúc nào.
Source - database | Page ID - 16993
Share CFD Trading FAQ
What is a Share CFD?
What is a Share CFD?
Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.
Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.
What is the difference between CFD and Shares?
What is the difference
between CFD and Shares?
Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.
While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.
What are the most traded share CFDs?
What are the most
traded share CFDs?
Supply and demand are the main two pillars of share price sharping. The economic situation of countries, in addition to geopolitical risks and instability, can undoubtedly affect trade, financial flow, and consequently the share CFDs prices. In such situations the stock market price fluctuations can be excessively strong, creating opportunities for traders to generate returns investing on the foreign exchange but also excessive risks.
Thus, some well-performing companies offer more opportunities to traders due to their stable, smooth, and less volatile share price movement in the markets. Some of the top traded share CFDs represent the trending industries.
Technology companies such as Tesla Inc, Apple, Microsoft, and Facebook are some of the trader’s favorite shares to trade according to Investing.com. While some of the biotech representatives that have entered the top traded list of the global markets are Moderna, Pfizer, and Johnson & Johnson.
What factors should I consider when trading Share CFDs?
What factors should I
consider when trading
Share CFDs?
The main two driving forces of the forex currency market‘s volatility are supply and demand, placing the share CFDs trading amongst the most distinct volatility performers in the markets.
The economic situation of countries and unions, in addition to geopolitical risks and instability, can undoubtedly affect trade, financial flow, and consequently the interest rate of currencies, economies, and companies. In such situations the stock market price fluctuations can be excessively strong, creating opportunities for traders to generate returns investing on the share CFDs.
For instance, the current global pandemic situation has resulted in traders’ interest turning towards pharmaceutical and biotech companies, delivery and transportation as well as streaming and production services.